Related Experiment Video
Updated: Aug 25, 2026

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
Phospholipase D in cellular senescence
1Biology Department, Appalachian State University, P.O. Box 32027, Boone, NC 28608-2027, USA. venableme@appstate.edu
Abstract:
Cellular senescence appears to be an important part of organismal aging. Cellular senescence is characterized by flattened enlarged morphology, inhibition of DNA replication in response to growth factors, inability to phosphorylate the pRb tumor suppressor protein, inability to produce c-fos or AP-1 and overexpression of a variety of genes, notably p21 (CIP-1/WAF-1) and p16(INK). It is now clear that certain early mitotic signals become defective with the onset of senescence. Among these is the PLD/PKC pathway. Evidence suggests that activation of PLD and PKC is critical for mitogenesis. Recent data suggest that the defect in PLD/PKC in cellular senescence is a result of elevated cellular ceramide levels which inhibit PLD activation. It appears that the elevated ceramide is a result of neutral sphingomyelinase activation. Ceramide acts to inhibit the activation of PLD by possibly three mechanisms, inhibiting activation by Rho, translocation to the membrane and gene expression. Addition of ceramide to young cells not only inhibits PLD but also recapitulates all the standard measures of cellular senescence as described above.
Insights
Cellular senescence, a hallmark of aging, involves defective early mitotic signals like the Phospholipase D (PLD)/Protein Kinase C (PKC) pathway. Elevated ceramide levels inhibit PLD activation, driving senescence.
Area of Science:
- Cellular and Molecular Biology
- Gerontology
- Biochemistry
Background:
- Cellular senescence is a key process in organismal aging, characterized by distinct morphological and molecular changes.
- Key features include growth arrest, altered gene expression (e.g., p21, p16), and defective early mitotic signaling pathways.
- The Phospholipase D (PLD)/Protein Kinase C (PKC) pathway is crucial for cell proliferation (mitogenesis).
Purpose of the Study:
- To investigate the molecular mechanisms underlying the defect in the PLD/PKC pathway during cellular senescence.
- To identify the role of ceramide in the pathogenesis of cellular senescence.
Main Methods:
- Analysis of gene and protein expression in senescent cells.
- Investigation of PLD and PKC pathway activation.
- Experimental manipulation of ceramide levels in young and senescent cells.
Main Results:
- Cellular senescence is associated with a defective PLD/PKC signaling pathway.
- Elevated cellular ceramide levels were identified as a cause of PLD activation inhibition.
- Neutral sphingomyelinase activation appears to be responsible for increased ceramide.
- Ceramide inhibits PLD activation through multiple mechanisms, including interference with Rho signaling, membrane translocation, and gene expression.
- Exogenous ceramide addition to young cells induced typical senescence phenotypes.
Conclusions:
- Elevated ceramide, resulting from neutral sphingomyelinase activation, is a critical mediator of cellular senescence by inhibiting the PLD/PKC pathway.
- Targeting ceramide metabolism or PLD/PKC signaling may offer therapeutic strategies for age-related conditions.
More Related Videos
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Replicative Cell Senescence
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
IP3/DAG Signaling Pathway
Cellular Injury IlI: Cellular Death
Cellular Injury V: Apoptosis and Autophagy

